Patents by Inventor Maryvonne Chariot

Maryvonne Chariot has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050202089
    Abstract: A sustained-release pharmaceutical formulation containing mizolastine, a core formed of a sustained-release table containing mizolastine combined with a fatty matrix and an organic acid, the tablet being coated.
    Type: Application
    Filed: January 3, 2005
    Publication date: September 15, 2005
    Applicant: SANOFI-SYNTHELABO
    Inventors: Maryvonne Chariot, Gareth Lewis, Jean Montel
  • Patent number: 6165507
    Abstract: A sustained-release pharmaceutical formulation containing mizolastine, a core formed of a sustained-release table containing mizolastine combined with a fatty matrix and an organic acid, the tablet being coated.
    Type: Grant
    Filed: August 26, 1998
    Date of Patent: December 26, 2000
    Assignee: Synthelabo
    Inventors: Maryvonne Chariot, Gareth Lewis, Jean Montel
  • Patent number: 5112621
    Abstract: A sustained-release pharmaceutical composition which comprises microparticles comprising an active principle, said microparticles being coated with a coating mixture comprising ethyl cellulose and an acrylic resin which is a polymerizate of acrylic and methacrylic ester, having a molecular weight of at least 100,000 and comprising units of formula: ##STR1## wherein: R.sub.1 is hydrogen or methyl,R.sub.2 is methyl or ethyl,R.sub.3 is methyl; andR.sub.4 is --CH.sub.2 --CH.sub.2 N(CH.sub.3).sub.3 Clthe resin containing 5% of trimethylammonium methacrylate chloride units by weight.
    Type: Grant
    Filed: July 26, 1990
    Date of Patent: May 12, 1992
    Assignee: Synthelabo
    Inventors: Howard Stevens, Maryvonne Chariot, Francoise Arnold, Gareth Lewis